Versant Ventures, which incubated the cell-based immunotherapy developer based on Harvard and Stanford research, has backed a $160m round.

Salesforce Ventures took part in a round that near tripled the valuation of the virtual events platform developer to $5.65bn in just four months.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Returning investor Leaps by Bayer was among the participants in the cell-based immunotherapy developer’s series C round having previously led a $250m round in 2019.

Heritage Medical Systems and AbbVie Ventures took part in genome editing technology developer Caribou Biosciences' first funding round in five years.

The Engine and Congruent Ventures have both participated in a series A round for the developer of high-voltage superconducting transmission lines.

UC Berkeley-founded genome editing technology developer Caribou Biosciences has completed its first funding round in five years.

The utility engagement software provider secured the funding in a round co-led by Schneider Electric and AES Corporation at a $1.5bn valuation.

The database platform developer will embark on international expansion with funding raised from investors including Dell Technologies Capital and Wipro Ventures.

Merck & Co is set to exit the genomic services and cancer diagnostics provider in an acquisition by Bio-Techne potentially sized at $320m.